India’s medical device sector is expanding rapidly, driven by increased healthcare investment, domestic manufacturing, and digital health innovation. As this sector grows, compliance with Indian medical device regulations has become essential for manufacturers, importers, distributors, and healthcare technology companies.
Under the Central Drugs Standard Control Organization framework, medical devices are regulated under the Medical Devices Rules, 2017, issued under the Drugs and Cosmetics Act, 1940. These rules define how devices are classified, grouped, tested, licensed, and monitored for safety before entering the Indian market.
If your company plans to manufacture or import medical devices in India, understanding these regulations is necessary for legal compliance and successful market entry.
What Is CDSCO and Why It Regulates Medical Devices?
Central Drugs Standard Control Organization is India’s national regulatory authority for medical devices, pharmaceuticals, and diagnostics. It operates under the Ministry of Health and Family Welfare.
The authority oversees:
- Device classification
- Import licensing
- Manufacturing licenses
- Clinical investigation approvals
- Quality standards
- Post-market surveillance
The official CDSCO classification list is updated regularly to reflect new technologies, including AI-enabled devices and software medical products.
Medical Device Classification in India (Risk-Based System)
India follows a risk-based classification system similar to international regulatory frameworks. Devices are categorized based on intended use, invasiveness, duration of contact, and patient risk.
Non-IVD Medical Devices
These are classified under Part I of the First Schedule.
|
Class |
Risk Level |
Examples |
|
A |
Low Risk |
Surgical gloves, manual wheelchairs |
|
B |
Low-Moderate Risk |
Needles, BP monitors |
|
C |
Moderate-High Risk |
Ventilators, orthopedic implants |
|
D |
High Risk |
Pacemakers, heart valves |
In Vitro Diagnostic (IVD) Devices
These fall under Part II of the First Schedule.
|
Class |
Risk Level |
Examples |
|
A |
Low Risk |
Reagents |
|
B |
Low-Moderate |
Glucose strips |
|
C |
Moderate-High |
HIV diagnostic kits |
|
D |
High Risk |
Blood grouping systems |
The Central Licensing Authority determines classification based on intended use and may revise categories when technologies evolve.
Medical Device Grouping for Licensing
Under Rule 5, manufacturers and importers may group related products in one licensing application.
This applies for:
- Import licenses
- Manufacturing licenses
- Sale and distribution permissions
Grouping is permitted where products share:
- Similar intended use
- Same design family
- Common technology
- Minor size/material variations
Examples include multiple sizes of:
- Catheters
- Stents
- Surgical kits
- Disposable tubing systems
Grouping reduces compliance costs and speeds regulatory approvals.
Essential Principles for Manufacturing Medical Devices in India
Manufacturers must demonstrate conformity with essential principles of safety and performance.
These include:
Design Requirements
- Intended purpose validation
- Safety-by-design
- Risk mitigation controls
Performance Requirements
- Clinical effectiveness
- Product consistency
- Verification and validation
Lifecycle Compliance
- Traceability
- Adverse event reporting
- Documentation retention
- Quality management systems
These principles align closely with global best practices under ISO systems.
Product Standards for Medical Devices
Indian regulations specify a hierarchy of standards.
1. Indian Standards (BIS)
The first preference is standards published by the Bureau of Indian Standards.
2. International Standards
Where BIS standards are unavailable:
- ISO
- IEC
- ASTM
- Pharmacopoeial standards
3. Manufacturer Standards
Only when neither Indian nor international standards apply, validated internal standards may be accepted.
This ensures both local compliance and global harmonization.
Licensing Requirements in India
Medical device licenses vary by risk class.
State Licensing Authority (SLA)
Usually handles:
- Class A
- Class B
Central Licensing Authority (CLA)
Usually handles:
- Class C
- Class D
Applicants typically submit through the SUGAM portal with:
- Device Master File
- Plant Master File
- ISO 13485 certificate
- Free Sale Certificate (for imports)
- Authorized Agent documentation
Emerging Regulatory Trends in 2026
India’s framework is expanding beyond traditional devices.
Key Focus Areas
- AI medical devices
- Software as Medical Device (SaMD)
- Digital diagnostics
- Remote monitoring systems
- Connected wearable devices
CDSCO has already issued draft guidance for medical device software classifications and assessments.
Common Compliance Challenges
Manufacturers often face:
- Incorrect classification
- Delayed approvals
- Incomplete technical documentation
- Grouping errors
- Standard mismatch
- Labeling non-compliance
Working with a regulatory consultant can significantly reduce approval timelines.
Final Thoughts
India’s medical device regulations are evolving rapidly. Businesses that understand classification, grouping, standards, and licensing can enter the market faster and avoid costly delays.
Whether you manufacture surgical equipment, diagnostic kits, implants, or digital health products, staying aligned with Central Drugs Standard Control Organization requirements is essential.
